研究実績

Multi-center, phase II study for combination therapy with pacritaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1(OGSG0302)

H. Takiuchi, H. Imamura, M. Imano, Y. Kimura, H. Ishida, T. Tsujinaka, H. Narahara, H. Furukawa. Multi-center, phase II study for combination therapy with pacritaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302), 2006 Gastrical Cancers Symposum, American Society of Clinical Oncology.

前の記事 次の記事 一覧ページへ戻る